So IMO the name of the game is not: get the holds lifted and score some points; game is: control the score board. We are under holds for Gilead’s benefit for HIV and for Covid\remdesivir. That does not stop us right now from pursuing NASH and or mTNBC, so why not do those trials and get safety along with them?

The true question becomes even with good numbers do we do well? Is it worth pursuing or do we just focus on buyout and partnerships. My vote is for the latter as I watch BP crush its competitors time after time.